Works in Cancer Chemotherapy & Pharmacology, 2013, Vol 71, Issue 4

Results: 34

Therapeutic targeting malignant mesothelioma with a novel 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate via its selective uptake by the proton-coupled folate transporter.
Published in:
2013
By:
- Cherian, Christina;
- Kugel Desmoulin, Sita;
- Wang, Lei;
- Polin, Lisa;
- White, Kathryn;
- Kushner, Juiwanna;
- Stout, Mark;
- Hou, Zhanjun;
- Gangjee, Aleem;
- Matherly, Larry H
Publication type:
journal article
Repeated radioimmunotherapy with 131I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma.
Published in:
2013
By:
- Kang, Hye Jin;
- Lee, Seung-Sook;
- Byun, Byung Hyun;
- Kim, Kyeong Min;
- Lim, Ilhan;
- Choi, Chang Woon;
- Suh, Cheolwon;
- Kim, Won Seog;
- Nam, Seung-Hyun;
- Lee, Soon Il;
- Eom, Hyeon Seok;
- Shin, Dong-Yeop;
- Lim, Sang Moo
Publication type:
journal article
Effect of TP53 codon 72 and MDM2 SNP309 polymorphisms on survival of gastric cancer among patients who receiving 5-fluorouracil-based postoperative adjuvant chemotherapy.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 1073, doi. 10.1007/s00280-013-2103-3
By:
- Wang, Shizhi;
- Chen, Lulu;
- Zhao, Qinghong;
- Rong, Huan;
- Wang, Meilin;
- Gong, Weida;
- Zhou, Jianwei;
- Wu, Dongmei;
- Zhang, Zhengdong
Publication type:
Article
A randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine monotherapy for advanced biliary tract cancer.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 973, doi. 10.1007/s00280-013-2090-4
By:
- Sasaki, Takashi;
- Isayama, Hiroyuki;
- Nakai, Yousuke;
- Ito, Yukiko;
- Yasuda, Ichiro;
- Toda, Nobuo;
- Kogure, Hirofumi;
- Hanada, Keiji;
- Maguchi, Hiroyuki;
- Sasahira, Naoki;
- Kamada, Hideki;
- Mukai, Tsuyoshi;
- Okabe, Yoshihiro;
- Hasebe, Osamu;
- Maetani, Iruru;
- Koike, Kazuhiko
Publication type:
Article
Erratum to: Pharmacokinetic-pharmacodynamic relationship of bosutinib in patients with chronic-phase chronic myeloid leukemia.
Published in:
2013
By:
- Hsyu, Poe-Hirr;
- Mould, Diane;
- Upton, Richard;
- Amantea, Michael
Publication type:
Correction Notice
Phase I dose-escalation study of docetaxel, nedaplatin, and 5-fluorouracil combination chemotherapy in patients with advanced esophageal cancer.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 853, doi. 10.1007/s00280-013-2076-2
By:
- Miyazaki, Tatsuya;
- Sohda, Makoto;
- Tanaka, Naritaka;
- Suzuki, Shigemasa;
- Ieta, Keisuke;
- Sakai, Makoto;
- Sano, Akihiko;
- Yokobori, Takehiko;
- Inose, Takanori;
- Nakajima, Masanobu;
- Fukuchi, Minoru;
- Ojima, Hitoshi;
- Kato, Hiroyuki;
- Kuwano, Hiroyuki
Publication type:
Article
A phase II study of oxaliplatin in combination with leucovorin and fluorouracil as first-line chemotherapy in patients with metastatic squamous cell carcinoma of esophagus.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 905, doi. 10.1007/s00280-013-2081-5
By:
- Wang, Jialei;
- Chang, Jianhua;
- Yu, Hui;
- Wu, Xianghua;
- Wang, Huijie;
- Li, Wenhua;
- Ji, Dongmei;
- Peng, Wei
Publication type:
Article
Combination of gemcitabine and carboplatin as first line treatment in elderly patients or those unfit for cisplatin-based chemotherapy with advanced transitional cell carcinoma of the urinary tract.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 1033, doi. 10.1007/s00280-013-2098-9
By:
- Park, Joo;
- Lee, Soon;
- Kim, Hye;
- Kang, Sung;
- Ko, Young;
- Kim, Seung;
- Kang, Seok;
- Park, Young;
- Choi, In;
- Oh, Sang;
- Sung, Deuk;
- Seo, Jae;
- Cheon, Jun;
- Kim, Yeul;
- Kim, Jun;
- Park, Kyong
Publication type:
Article
A mathematical model for the administration of temozolomide: comparative analysis of conventional and metronomic chemotherapy regimens.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 1013, doi. 10.1007/s00280-013-2095-z
By:
- Faivre, C.;
- Barbolosi, D.;
- Pasquier, E.;
- André, N.
Publication type:
Article
A phase I study of tasisulam sodium using an albumin-tailored dose in Japanese patients with advanced solid tumors.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 991, doi. 10.1007/s00280-013-2092-2
By:
- Fujiwara, Yutaka;
- Ando, Yuichi;
- Mukohara, Toru;
- Kiyota, Naomi;
- Chayahara, Naoko;
- Mitsuma, Ayako;
- Inada-Inoue, Megumi;
- Sawaki, Masataka;
- Ilaria, Robert;
- Kellie Turner, P.;
- Funai, Jumpei;
- Maeda, Kaijiro;
- Minami, Hironobu
Publication type:
Article
Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 829, doi. 10.1007/s00280-012-2043-3
By:
- Burris, Howard
Publication type:
Article
Repeated radioimmunotherapy with I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 945, doi. 10.1007/s00280-013-2087-z
By:
- Kang, Hye;
- Lee, Seung-Sook;
- Byun, Byung;
- Kim, Kyeong;
- Lim, Ilhan;
- Choi, Chang;
- Suh, Cheolwon;
- Kim, Won;
- Nam, Seung-Hyun;
- Lee, Soon;
- Eom, Hyeon;
- Shin, Dong-Yeop;
- Lim, Sang
Publication type:
Article
A phase I study of hepatic arterial infusion of nab-paclitaxel in combination with intravenous gemcitabine and bevacizumab for patients with advanced cancers and predominant liver metastases.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 955, doi. 10.1007/s00280-013-2088-y
By:
- Tsimberidou, Apostolia;
- Ye, Yang;
- Wheler, Jennifer;
- Naing, Aung;
- Hong, David;
- Nwosu, Uchechi;
- Hess, Kenneth;
- Wolff, Robert
Publication type:
Article
All-oral combination of vinorelbine and capecitabine as first-line treatment in HER2/Neu-negative metastatic breast cancer.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 913, doi. 10.1007/s00280-013-2082-4
By:
- Tawfik, Hesham;
- Rostom, Yousri;
- Elghazaly, Hesham
Publication type:
Article
Phase I and pharmacokinetic study of gefitinib and S-1 combination therapy for advanced adenocarcinoma of the lung.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 859, doi. 10.1007/s00280-013-2077-1
By:
- Kiyota, Hidemi;
- Okamoto, Isamu;
- Takeda, Masayuki;
- Daga, Haruko;
- Naito, Tateaki;
- Miyazaki, Masaki;
- Okada, Hideaki;
- Hayashi, Hidetoshi;
- Tanaka, Kaoru;
- Terashima, Masaaki;
- Azuma, Koichi;
- Murakami, Haruyasu;
- Takeda, Koji;
- Yamamoto, Nobuyuki;
- Nakagawa, Kazuhiko
Publication type:
Article
Thrombocytosis and immunohistochemical expression of connexin 43 at diagnosis predict survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 893, doi. 10.1007/s00280-013-2080-6
By:
- Du, Gangjun;
- Yang, Yingming;
- Zhang, Yaping;
- Sun, Ting;
- Liu, Weijie;
- Wang, Yingying;
- Li, Jiahuan;
- Zhang, Houyun
Publication type:
Article
Correlation between expressions of ERCC1/TS mRNA and effects of gastric cancer to chemotherapy in the short term.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 921, doi. 10.1007/s00280-013-2083-3
By:
- Chen, Liqi;
- Li, Guoli;
- Li, Jieshou;
- Fan, Chaogang;
- Xu, Jian;
- Wu, Bo;
- Liu, Kun;
- Zhang, Caihua
Publication type:
Article
An integrin-targeted, pan-isoform, phosphoinositide-3 kinase inhibitor, SF1126, has activity against multiple myeloma in vivo.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 867, doi. 10.1007/s00280-013-2078-0
By:
- De, Pradip;
- Dey, Nandini;
- Terakedis, Breanne;
- Bergsagel, P.;
- Li, Zhi;
- Mahadevan, Daruka;
- Garlich, Joseph;
- Trudel, Suzanne;
- Makale, Milan;
- Durden, Donald
Publication type:
Article
Genetic basis for the increased expression of vacuolar H translocating ATPase genes upon imatinib treatment in human lymphoblastoid cells.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 1095, doi. 10.1007/s00280-013-2110-4
By:
- Kulkarni, Hemant;
- Göring, Harald;
- Curran, Joanne;
- Diego, Vincent;
- Dyer, Thomas;
- Cole, Shelley;
- Walder, Ken;
- Collier, Greg;
- Blangero, John;
- Carless, Melanie
Publication type:
Article
Therapeutic targeting malignant mesothelioma with a novel 6-substituted pyrrolo[2,3- d]pyrimidine thienoyl antifolate via its selective uptake by the proton-coupled folate transporter.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 999, doi. 10.1007/s00280-013-2094-0
By:
- Cherian, Christina;
- Kugel Desmoulin, Sita;
- Wang, Lei;
- Polin, Lisa;
- White, Kathryn;
- Kushner, Juiwanna;
- Stout, Mark;
- Hou, Zhanjun;
- Gangjee, Aleem;
- Matherly, Larry
Publication type:
Article
A multi-histology trial of fostamatinib in patients with advanced colorectal, non-small cell lung, head and neck, thyroid, and renal cell carcinomas, and pheochromocytomas.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 981, doi. 10.1007/s00280-013-2091-3
By:
- Park, Sook;
- Speranza, Giovanna;
- Piekarz, Richard;
- Wright, John;
- Kinders, Robert;
- Wang, Lihua;
- Pfister, Thomas;
- Trepel, Jane;
- Lee, Min-Jung;
- Alarcon, Sylvia;
- Steinberg, Seth;
- Collins, Jerry;
- Doroshow, James;
- Kummar, Shivaani
Publication type:
Article
The PPARγ agonist pioglitazone crosses the blood-brain barrier and reduces tumor growth in a human xenograft model.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 929, doi. 10.1007/s00280-013-2084-2
By:
- Grommes, Christian;
- Karlo, J.;
- Caprariello, Andrew;
- Blankenship, D'Arbra;
- DeChant, Anne;
- Landreth, Gary
Publication type:
Article
A phase 2 study of KX2-391, an oral inhibitor of Src kinase and tubulin polymerization, in men with bone-metastatic castration-resistant prostate cancer.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 883, doi. 10.1007/s00280-013-2079-z
By:
- Antonarakis, Emmanuel;
- Heath, Elisabeth;
- Posadas, Edwin;
- Yu, Evan;
- Harrison, Michael;
- Bruce, Justine;
- Cho, Steve;
- Wilding, Gregory;
- Fetterly, Gerald;
- Hangauer, David;
- Kwan, Min-Fun;
- Dyster, Lyn;
- Carducci, Michael
Publication type:
Article
Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 843, doi. 10.1007/s00280-013-2075-3
By:
- Lee, Kyung-Hun;
- Chang, Hye;
- Han, Sae-Won;
- Oh, Do-Youn;
- Im, Seock-Ah;
- Bang, Yung-Jue;
- Kim, Sun;
- Lee, Keun-Wook;
- Kim, Jee;
- Hong, Yong;
- Kim, Tae;
- Park, Young;
- Kang, Won;
- Shin, Sang;
- Ahn, Joong;
- Kang, Gyeong;
- Jeong, Seung-Yong;
- Park, Kyu;
- Park, Jae-Gahb;
- Kim, Tae-You
Publication type:
Article
Reply to: Clusterin inhibition to enhance tumor chemosensitivity in systemic tumors.
Published in:
2013
By:
- Cheng, Ching-Yuan;
- Cherng, Shur-Hueih;
- Wu, Wen-Jun;
- Yang, Tsung-Ying;
- Huang, Xin-Yi;
- Liao, Fu-Tien;
- Wu, Ming-Fang;
- Sheu, Gwo-Tarng
Publication type:
Letter
Phase I/II study of albumin-bound nab-paclitaxel plus gemcitabine administered to Chinese patients with advanced pancreatic cancer.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 1065, doi. 10.1007/s00280-013-2102-4
By:
- Zhang, Dong-sheng;
- Wang, De-shen;
- Wang, Zhi-qiang;
- Wang, Feng-hua;
- Luo, Hui-yan;
- Qiu, Miao-zhen;
- Wang, Feng;
- Li, Yu-hong;
- Xu, Rui-hua
Publication type:
Article
Multicenter phase II study of S-1 and docetaxel combination chemotherapy for advanced or recurrent gastric cancer patients with peritoneal dissemination.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 937, doi. 10.1007/s00280-013-2086-0
By:
- Shigeyasu, Kunitoshi;
- Kagawa, Shunsuke;
- Uno, Futoshi;
- Nishizaki, Masahiko;
- Kishimoto, Hiroyuki;
- Gochi, Akira;
- Kimura, Toshikazu;
- Takahata, Takaomi;
- Nonaka, Yasuyuki;
- Ninomiya, Motoki;
- Fujiwara, Toshiyoshi
Publication type:
Article
Phase I study to assess the pharmacokinetics and the effect on cardiac repolarization of amrubicin and amrubicinol in patients with advanced solid tumors.
Published in:
2013
By:
- Chen, Nianhang;
- Chawla, Sant;
- Chiorean, Elena;
- Read, William;
- Gorbaty, Mayer;
- Mita, Alain;
- Yung, Lotus;
- Bryan, Peter;
- McNally, Richard;
- Renschler, Markus;
- Sharma, Sunil
Publication type:
Report
Pharmacodynamic stimulation of thrombogenesis by angiotensin (1-7) in recurrent ovarian cancer patients receiving gemcitabine and platinum-based chemotherapy.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 965, doi. 10.1007/s00280-013-2089-x
By:
- Pham, Huyen;
- Schwartz, Benjamin;
- Delmore, James;
- Reed, Eddie;
- Cruickshank, Scott;
- Drummond, Leanne;
- Rodgers, Kathleen;
- Peterson, Kainoa;
- diZerega, Gere
Publication type:
Article
Anti-tumour and anti-vascular effects of cediranib (AZD2171) alone and in combination with other anti-tumour therapies.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 1021, doi. 10.1007/s00280-013-2097-x
By:
- Kendrew, Jane;
- Odedra, Rajesh;
- Logié, Armelle;
- Taylor, Paula;
- Pearsall, Sharon;
- Ogilvie, Donald;
- Wedge, Stephen;
- Jürgensmeier, Juliane
Publication type:
Article
Multicenter phase II trial of preoperative chemoradiotherapy with S-1 for locally advanced oral squamous cell carcinoma.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 1059, doi. 10.1007/s00280-013-2101-5
By:
- Harada, Hiroyuki;
- Omura, Ken;
- Tomioka, Hirofumi;
- Nakayama, Hideki;
- Hiraki, Akimitsu;
- Shinohara, Masanori;
- Yoshihama, Yasuto;
- Shintani, Satoru
Publication type:
Article
A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 1041, doi. 10.1007/s00280-013-2099-8
By:
- Sandhu, Shahneen;
- Papadopoulos, Kyri;
- Fong, Peter;
- Patnaik, Amita;
- Messiou, Christina;
- Olmos, David;
- Wang, George;
- Tromp, Brenda;
- Puchalski, Thomas;
- Balkwill, Frances;
- Berns, Birge;
- Seetharam, Shobha;
- Bono, Johann;
- Tolcher, Anthony
Publication type:
Article
The Breast Avastin Trial: phase II study of bevacizumab maintenance therapy after induction chemotherapy with docetaxel and capecitabine for the first-line treatment of patients with locally recurrent or metastatic breast cancer.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 1051, doi. 10.1007/s00280-013-2100-6
By:
- Bisagni, G.;
- Musolino, A.;
- Panebianco, M.;
- Matteis, A.;
- Nuzzo, F.;
- Ardizzoni, A.;
- Gori, S.;
- Gamucci, T.;
- Passalacqua, R.;
- Gnoni, R.;
- Moretti, G.;
- Boni, C.
Publication type:
Article
Clusterin inhibition to enhance tumor chemosensitivity in systemic tumors.
Published in:
2013
By:
- Kapoor, Shailendra
Publication type:
Letter